Nitric Oxide and Cyclic GMP Signaling
暂无分享,去创建一个
[1] Johannes Benkhoff. messenger , 2021, Birth….
[2] M. Marletta,et al. Nitric oxide synthase: Aspects concerning structure and catalysis , 1994, Cell.
[3] J. Stamler,et al. Redox signaling: Nitrosylation and related target interactions of nitric oxide , 1994, Cell.
[4] Carl Nathan,et al. Nitric oxide synthases: Roles, tolls, and controls , 1994, Cell.
[5] U. Walter,et al. NO at work , 1994, Cell.
[6] R Fischmeister,et al. Nitric oxide regulates cardiac Ca2+ current. Involvement of cGMP-inhibited and cGMP-stimulated phosphodiesterases through guanylyl cyclase activation. , 1993, The Journal of biological chemistry.
[7] A. Galione,et al. cGMP mobilizes intracellular Ca2+ in sea urchin eggs by stimulating cyclic ADP-ribose synthesis , 1993, Nature.
[8] U. Walter,et al. The nitric oxide and cGMP signal transduction system: regulation and mechanism of action. , 1993, Biochimica et biophysica acta.
[9] T. Lincoln,et al. Intracellular cyclic GMP receptor proteins , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[10] J. Stamler,et al. Biochemistry of nitric oxide and its redox-activated forms. , 1992, Science.
[11] D. Garbers. Guanylyl cyclase receptors and their endocrine, paracrine, and autocrine ligands , 1992, Cell.
[12] G. Rubanyi. Endothelium‐derived relaxing and contracting factors , 1991, Journal of cellular biochemistry.
[13] F. Murad,et al. Expression of soluble guanylate cyclase activity requires both enzyme subunits. , 1991, Biochemical and biophysical research communications.
[14] R. Haslam,et al. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP. , 1990, Molecular pharmacology.
[15] F. Murad,et al. The involvement of catalytic site thiol groups in the activation of soluble guanylate cyclase by sodium nitroprusside. , 1986, Archives of biochemistry and biophysics.
[16] F. Murad,et al. Cyclic guanosine monophosphate as a mediator of vasodilation. , 1986, The Journal of clinical investigation.
[17] F. Murad,et al. Soluble guanylate cyclase from rat lung exists as a heterodimer. , 1986, The Journal of biological chemistry.
[18] F. Murad,et al. Co-purification of an atrial natriuretic factor receptor and particulate guanylate cyclase from rat lung. , 1986, The Journal of biological chemistry.
[19] F. Murad,et al. Reversible inactivation of guanylate cyclase by mixed disulfide formation. , 1981, The Journal of biological chemistry.
[20] F. Murad,et al. Effects of thiols, sugars, and proteins on nitric oxide activation of guanylate cyclase. , 1979, The Journal of biological chemistry.
[21] F. Murad,et al. Synthesis of adenosine 3',5'-monophosphate by guanylate cyclase, a new pathway for its formation. , 1979, Biochimica et biophysica acta.
[22] F. Murad,et al. Nitric oxide activates guanylate cyclase and increases guanosine 3':5'-cyclic monophosphate levels in various tissue preparations. , 1977, Proceedings of the National Academy of Sciences of the United States of America.
[23] F. Murad,et al. Effects of sodium nitroprusside, nitroglycerin, and sodium azide on levels of cyclic nucleotides and mechanical activity of various tissues. , 1977, Journal of cyclic nucleotide research.
[24] F. Murad,et al. Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerin and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hydroxylamine. , 1977, Journal of cyclic nucleotide research.
[25] F. Murad,et al. Evidence for two different forms of guanylate cyclase in rat heart. , 1974, The Journal of biological chemistry.
[26] F. Murad,et al. Regulation of cytosolic guanylyl cyclase by nitric oxide: the NO-cyclic GMP signal transduction system. , 1994, Advances in pharmacology.
[27] F. Murad,et al. Cloning of guanylyl cyclase isoforms. , 1994, Advances in pharmacology.
[28] F. Murad,et al. Regulation of particulate guanylate cyclase by natriuretic peptides and Escherichia coli heat-stable enterotoxin. , 1994, Advances in pharmacology.
[29] F. Murad,et al. Interrelationships of cyclic GMP, inositol phosphates, and calcium. , 1994, Advances in pharmacology.
[30] A. Vaandrager,et al. Effect of cyclic GMP on intestinal transport. , 1994, Advances in pharmacology.
[31] W. K. Sonnenburg,et al. Cyclic GMP and regulation of cyclic nucleotide hydrolysis. , 1994, Advances in pharmacology.
[32] O. Griffith,et al. The surprising life of nitric oxide , 1993 .
[33] C. Lugnier,et al. Modulation of vascular cyclic nucleotide phosphodiesterases by cyclic GMP: role in vasodilatation. , 1993, European heart journal.
[34] J Pollock,et al. The nitric oxide-cyclic GMP signal transduction system for intracellular and intercellular communication. , 1993, Advances in second messenger and phosphoprotein research.
[35] D. Garbers,et al. The expanding family of guanylyl cyclases. , 1991, Trends in pharmacological sciences.
[36] F. Murad,et al. Properties of purified soluble guanylate cyclase activated by nitric oxide and sodium nitroprusside. , 1982, Journal of cyclic nucleotide research.